Follow us for updates
© 2021 reportr.world
Read the Story →

Enrique Razon to Help Fund Philippines' COVID Vaccine Purchases

The private sector is joining the vaccine rush.
by Joel Guinto
Nov 24, 2020
An undated handout picture released by the University of Oxford on Nov. 23, 2020 shows a technician working at the Jenner Institute on the University's COVID-19 candidate vaccine, known as AZD1222, co-invented by the University of Oxford and Vaccitech.
Photo/s: Agence France-Presse
Shares

Ports billionaire Enrique Razon will help the government buy COVID-19 vaccines, which could arrive as early as the second quarter of 2021, an executive of his company said Tuesday.

Razon will shoulder the full cost of a portion of the country's vaccine requirement, half of which will be given to employees of his conglomerate while the remainder will be reserved for port and customs employees and logistics frontliners, said Christian Razon Gonzalez, executive vice president of International Container Terminal Services Inc.

MORE ON VACCINES:

Did Sen. Lacson Get a COVID-19 Vaccine? 

What is the Philippines COVID-19 Vaccine Plan?

The vaccines will be sourced from the UK's Astra Zeneca, Gonzalez told a government briefing. The Philippines has programmed an initial procurement of 60 million vaccines, of which 2 million will be brought in by the private sector, he said.

"This is just a way for us to contribute to the effort of the national government," he said.

Continue reading below ↓

ALSO READ:

Pfizer Seeks First Vaccine Approval in U.S.

Meet Moderna, the Firm Behind COVID Vaccine Breakthrough

President Rodrigo Duterte's administration is in talks with three pharmaceutical firms working on COVID-19 vaccines, said the Philippines' vaccine czar, Sec. Carlito Galvez.

The Philippines plans to prioritize poor families, health workers, and law enforcers in its COVID-19 vaccination program, he said.

Continue reading below ↓
Recommended Videos
Latest Headlines
Read Next
Recent News
The news. So what? Subscribe to the newsletter that explains what the news means for you.
The email address you entered is invalid.
Thank you for signing up to On Three, reportr's weekly newsletter delivered to your mailbox three times a week. Only the latest, most useful and most insightful reads.
By signing up to reportr.world newsletter, you agree to our Terms of Service and Privacy Policy.